Company Analysis

EUDA Health Holdings Limited (EUDA)

Nasdaq: EUDA · Services-Health Services · filing with the SEC since 2021
Grade4.2
◀ Past 3.4● Present 2.9▶ Future 6.6
2 est.

The grade of EUDA Health Holdings Limited

Nine metrics read from its own filings, by tense
Headline grade
4.2/10
◀ Past3.430% of the headline
● Present2.940% of the headline
▶ Future6.630% of the headline

All three tenses have at least two readings, so the archetype blend applies as printed.

Of the nine metrics, 7 read as filed from the record and 2 are SI estimates, each with its reasoning, its confidence and what would change it on its card.

◀ Past

What did they actually do?

3.4/1030% of the headline grade · 2 of 3 filed, 1 estimated

Surviving crises

as filed
5.3/10

Has it survived what it has been through?

8 warning events since 2021; the latest 2024-04-30.

weight 33% of this tense · 53rd percentile among 15 sector filers · read for itself

From the record

EUDA Health Holdings Limited's filings since 2021 show 8 warning events of 3 kinds: a notice about its exchange listing (8-K item 3.01, 4 times, the latest 2023-06-15); an auditor change (8-K item 4.01, the latest 2022-11-23); a late-report notice (Form NT 10-K or NT 10-Q, 3 times, the latest 2024-04-30) (its current reports).

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Track record

as filed
2.3/10

What has it actually done, year after year?

+10.6% a year over 5 filed years; profitable in 1 of 6.

weight 45% of this tense · 23rd percentile among 14 sector filers · read for its customers

From the record

EUDA Health Holdings Limited's 5 filed years say what it did: revenue went from $5 million in fiscal 2021 to $7 million in fiscal 2025, up 10.6% a year; it rose in 2 of 4 years; the deepest fall was 19% from fiscal 2021 to fiscal 2023; net income was positive in 1 of 6 of those years (its annual reports).

What it rests on

  • revenue growth over the filed span10.6%bottom 18% of its family
  • the share of years revenue rosebottom 4% of its family
  • the share of filed years with a profitbottom 46% of its family
  • the deepest fall from a revenue peak18.7%bottom 25% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Shareholder treatment

SI estimate
2.5/10

How has it treated the people who own it?

SI estimate 2.5/10, confidence 35 of 100 (one part).

weight 22% of this tense · 25th percentile among 14 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate
Read from one part only, the share count over the years, which ranks in the bottom 25% of 14 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
What the record cannot read
Fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
How it was reasoned
one part: the share count over the years, the one part on file, ranked among 14 in its family.
Confidence
35 of 100
What would change it
A filing that carries the missing parts replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: EUDA Health Holdings Limited's shareholder treatment is put at 2.5 of 10 with a confidence of 35 of 100, because read from one part only, the share count over the years, which ranks in the bottom 25% of 14 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income. A filing that carries the missing parts replaces this estimate with the filed reading.

● Present

What are they doing right now?

2.9/1040% of the headline grade · 2 of 3 filed, 1 estimated

Financial health

as filed
4.1/10

Is it financially healthy right now?

Leverage 348%: owes 348¢ per asset dollar.

weight 33% of this tense · 41st percentile among 14 sector filers · read for itself

From the record

Return on equity: in the fiscal year ended 2025-12-31, EUDA Health Holdings Limited's shareholders' equity was below zero, so the profit on it is not read, and gross profitability: its products earned about 174 cents per dollar of everything the company owns. Leverage: it owed about 348 cents per dollar of assets, and net share issuance: its share count grew 15.1% over the year (the filed statements).

What it rests on

  • what it owes per dollar of assetsbottom 4% of its family
  • gross profit against assetstop 6% of its family
  • the share count against the year beforebottom 25% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Industry position

as filed
3.2/10

How strong is its position in its industry?

bottom 32% of 14 in its family; net margin -40.7%.

weight 45% of this tense · 32nd percentile among 14 sector filers · read for its customers

From the record

EUDA Health Holdings Limited's standing among 14 graded names in its industry family: revenue of $7 million in fiscal 2025 ranks in the bottom 11% by size; a net margin of -40.7% ranks in the bottom 25%; revenue growth of 21.9% a year over the last 3 filed years ranks in the top 39% (its annual reports).

What it rests on

  • revenue against the family$6.8Mbottom 11% of its family
  • net margin-40.7%bottom 25% of its family
  • three-year revenue growth21.9%top 39% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Leadership

SI estimate
0.5/10

What are the people in charge doing?

SI estimate 0.5/10, confidence 35 of 100 (one part).

weight 22% of this tense · 5th percentile among 13 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate
Read from one part only, the median years the people in charge have been filing, which ranks in the bottom 5% of 13 in its family; it files no Form 8-K (a foreign issuer reports on Form 6-K), so officer and director changes cannot be read there.
What the record cannot read
It files no Form 8-K (a foreign issuer reports on Form 6-K), so officer and director changes cannot be read there.
How it was reasoned
one part: the median years the people in charge have filed, the one part on file, ranked among 13 in its family.
Confidence
35 of 100
What would change it
A filing that carries the missing parts replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: EUDA Health Holdings Limited's leadership is put at 0.5 of 10 with a confidence of 35 of 100, because read from one part only, the median years the people in charge have been filing, which ranks in the bottom 5% of 13 in its family; it files no Form 8-K (a foreign issuer reports on Form 6-K), so officer and director changes cannot be read there. A filing that carries the missing parts replaces this estimate with the filed reading.

▶ Future

What are they set up to do next?

6.6/1030% of the headline grade · 3 of 3 filed

Room to expand

as filed
3.3/10

How much room does it have to grow?

bottom 33% of 14 in its family for room to expand.

weight 22% of this tense · 33rd percentile among 14 sector filers · read for itself

From the record

EUDA Health Holdings Limited's room to grow, from the newest filed statements (fiscal 2025): cash of $345 thousand against no long-term debt tagged leaves 20.1% of its assets as net cash, top 32% of its family; cash from operations less capital spending is -36.7% of revenue (bottom 11%); a gross margin of 43.9% (bottom 44%); research spending of 0% of revenue (bottom 10%) (its annual report).

What it rests on

  • cash less debt against assets20.1%top 32% of its family
  • cash from operations less capital spending against revenue-36.7%bottom 11% of its family
  • gross margin43.9%bottom 44% of its family
  • research spending against revenue0.0%bottom 10% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Growth drivers

as filed
7.5/10

What could actually drive growth from here?

top 25% of 14 in its family for growth drivers.

weight 45% of this tense · 75th percentile among 14 sector filers · read for its customers

From the record

EUDA Health Holdings Limited's growth drivers, from the filed years to fiscal 2025: revenue grew 21.9% a year over the last three filed years against 10.6% over all 5, speeding up (top 4% of its family); the newest year grew 70.1% (top 4%); research spending grew -79.1% a year (bottom 10%); capital spending grew 189.4% a year (top 4%) (its annual reports). EUDA Health Holdings Limited reported 7 product lines in fiscal 2025: Property Management Service Common Area Management at $3 million (48%), Wellness Therapies Service at $2 million (26%), Property Management Service Security Management at $1 million (16%), and 4 more; 6 of 6 grew against the year before (its annual report).

What it rests on

  • three-year growth against the whole span+11.3 points a yeartop 4% of its family
  • the newest year's revenue growth70.1%top 4% of its family
  • three-year growth of research spending-79.1%bottom 10% of its family
  • three-year growth of capital spending189.4%top 4% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Expectations vs reality

as filed
7.6/10

Did its newest year beat what its own record pointed to?

top 24% of 12 in its family for expectations against reality.

weight 33% of this tense · 76th percentile among 12 sector filers · read for its shareholders

From the record

EUDA Health Holdings Limited's newest year against its own record: revenue of $7 million in fiscal 2025 came in 64.7% above the $4 million its prior three years' pace pointed to (top 4% of its family); net income of $3 million against a prior three-year average of $17 million (bottom 38%); a net margin of -40.7% against losses larger than its revenue before (top 4%) (its annual reports).

What it rests on

  • revenue against the prior three years' pace64.7%top 4% of its family
  • net income against the prior three years' average+84%bottom 38% of its family
  • net margin against its prior averageup more than 100 pointstop 4% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made

SI Assistanton EUDA · research, not advice